GLP1R and osteoporosis: In contrast, previous studies have shown that some GMs produce serotonin that crosses the intestinal barrier and enters the bloodstream and that serotonin reduces the secretion of GLP-1, which in turn reduces the production of osteoblasts, inhibits bone formation, and leads to osteoporosis (Yadav et al., 2010).